Background
Hepatic sinusoidal obstruction syndrome (HSOS), also referred to as hepatic veno-occlusive illness, is a vascular illness wherein endothelial cells within the hepatic sinusoids, small hepatic veins, and interlobular veins bear oedema and necrosis resulting from a number of causes, resulting in microthrombosis, subsequent congestive liver harm, and portal hypertension.1 HSOS largely happens after hematopoietic stem cell transplantation. In China, it primarily happens after the administration of pyrrolidine alkaloid (PA)-containing herbs, similar to Gynura segetum.2 HSOS is clinically manifested by signs similar to liver ache, ascites, and jaundice, and is usually recognized as hepatitis, liver cirrhosis, Budd-Chiari syndrome (BCS), or unexplained liver illness.
Portal hypertension can happen resulting from pre-sinusoidal, sinusoidal, and post-sinusoidal obstruction and result in liver harm. Apart from heart-induced congestive hepatopathy (CH), post-sinusoidal obstruction is especially divided into two classes in response to the extent of obstruction: (1) HSOS: on the degree of sinusoids and terminal venules, (2) BCS: from the hepatic vein to the superior finish of inferior vena cava.3,4
As a result of lack of specificity within the scientific manifestation of HSOS, early prognosis is troublesome and it’s typically confused with BCS in scientific observe. Just a few research analyzed their scientific imaging options. This examine retrospectively analyzed 20 circumstances of HSOS and explored the scientific testing parameters and computed tomography (CT) imaging options of HSOS to enhance the scientific understanding and prognosis of this illness.
Goal
This examine aimed to research the scientific options and CT manifestations of HSOS brought on by Gynura segetum, a Chinese language natural drugs, in order to enhance the scientific understanding and prognosis of this illness.
Supplies and Strategies
Scientific Knowledge
This examine retrospectively analyzed 36 sufferers with post-sinusoidal portal hypertension. Amongst them, 20 have been sufferers with HSOS, and 16 have been sufferers with BCS. These sufferers have been referred to or sought Medical care within the Division of Hepatology, Nanjing Second Hospital from January 2016 to December 2019 resulting from stomach distension, anorexia, asthenia, and hepatic dysfunction.
All HSOS sufferers had a particular historical past of administration Gynura segetum, together with 13 circumstances of oral administration and seven circumstances of consuming Gynura segetum wine. The earliest signs can seem as early as 3 days, and the longest can take as much as one yr after taking Gynura segetum. Roughly 50% of sufferers developed signs between 15 and 30 days after taking Gynura segetum. Their diagnoses have been confirmed by liver biopsy.
The diagnostic standards of HSOS have been as follows: (1) hepatomegaly and hepatalgia; (2) jaundice; (3) ascites or weight achieve over 2% of baseline. This examine additionally included sufferers with at the very least two of the three signs described above however with out different sorts of liver illness, similar to viral, autoimmune, or metabolic liver illness. 15 of the included HSOS circumstances underwent ultrasound-guided liver biopsy, and 5 underwent transjugular vein liver biopsy.
The experimental knowledge assortment was accredited by the Ethics Committee of Jiangsu Most cancers Hospital and the Second Hospital of Nanjing. This examine was not thought-about to impose a further burden on sufferers, trigger harm to sufferers or have an effect on their remedy, and didn’t violate sufferers’ privateness. Earlier than the beginning of the examine, every affected person was knowledgeable that related pictures and scientific knowledge through the remedy have been used for Analysis and evaluation. Sufferers’ private data was not disclosed and the consent of the sufferers was obtained. We affirm that the examine complies with the Declaration of Helsinki.
Picture Evaluation
All 20 HSOS sufferers and 16 BCS sufferers underwent plain, enhanced, and delayed CT scans. 5 BCS sufferers additionally underwent digital substruction angiography (DSA). All imaging knowledge have been retrospectively analyzed by two skilled radiologists. In line with revealed literature,5 CT pictures of the HSOS circumstances have been primarily analyzed for the next parameters and options: liver quantity (head-tail > 18 cm), hepatic vein stenosis (proper hepatic vein diameter < 4.5 mm), gallbladder wall thickening (wall thickness > 3 mm), diploma of ascites, and map-like heterogeneous enhancement of liver parenchyma within the venous and delayed phases. The diploma of enhancement was divided into three ranges in response to the vary of heterogeneous enhancement: Degree 1 is the delicate heterogeneous enhancement in a small liver phase; Degree 2 is the confluent heterogeneous enhancement in most liver segments; Degree 3 is the diffuse confluent heterogeneous enhancement all through the complete liver.6 BCS was brought on by a hepatic venous obstruction in 5 of the sufferers, inferior vena cava obstruction in 3 of the sufferers, and eight circumstances suffered from a mixture of the 2 circumstances.
Statistical Evaluation
Knowledge evaluation was carried out utilizing statistical software program SPSS 20.0 (IBM Corp., Armonk, NY, USA), and all variables have been examined for normality utilizing the Shapiro-Wilk check. For variables which have a standard distribution, an unbiased samples t-test was carried out. For variables that would not have a standard distribution, a nonparametric rank-sum check was carried out. A p < 0.05 signifies a statistically vital distinction.
Outcomes
Outcomes of Scientific and Laboratory Assessments
There have been 20 sufferers with HSOS, 16 males and 4 females, aged 39–74 years with a mean age of 61.0 ± 7.42 years. There have been 16 sufferers with BCS, 9 males and seven females, aged 22–64 years, with a mean age of 45.88 ± 11.88 years (Table 1).
 |
Desk 1 Laboratory Parameters of Hepatic Sinuscirrhotic Syndrome and Budd–Chiari Syndrome |
The pink blood cell, hemoglobin, and white blood cell counts in HSOS sufferers have been all inside the regular vary, however have been considerably greater than these in sufferers with BCS (p < 0.05). There was no vital distinction within the platelet counts between the 2 teams (Table 1). The degrees of indicators of liver harm in HSOS sufferers, aspartate aminotransferase and alanine aminotransferase, have been greater than the traditional ranges and have been considerably greater than these in BCS sufferers (p < 0.05). The degrees of alkaline phosphatase and glutamyl transpeptidase, indicators of cholestasis, have been additionally elevated in HSOS sufferers, and the distinction was statistically vital between the 2 teams (p < 0.05). On the identical time, the albumin degree and prothrombin time, which mirror liver synthesis operate, have been decreased and extended, respectively, within the sufferers with HSOS, and the distinction between the 2 teams was statistically vital (p < 0.05) (Table 1).
Outcomes of Imaging Examination and Pathological Examination
Ascites, heterogeneous hypoattenuation, and heterogeneous enhancement are a very powerful imaging manifestations of HSOS (Figure 1A–C). The prevalence was as follows: ascites (100%, 20/20), heterogeneous hypoattenuation (100%, 20/20), and heterogeneous enhancement (95%, 18/20) (Table 2). Moreover, heterogeneous enhancement was divided into three ranges in response to the enhancement vary as proven in Figure 2. The prevalence of the three manifestations was considerably decrease in BCS sufferers than in HSOS sufferers.
 |
Desk 2 Imaging Options of Hepatic Sinuscirrhotic Syndrome and Budd-Chiari Syndrome |
 |
Determine 1 CT manifestations and pathological photos of hepatic sinusoidal obstruction syndrome. (A–C) Imaging manifestations of hepatic sinusoidal obstruction syndrome on plain CT scans, arterial section CT scans, and venous section CT scans. (D) Clover-like enhancement within the second porta hepatis (arrowhead) on delayed-phase CT scans. (E) Sagittal multiplanar reconstruction exhibiting stenosis of the hepatic inferior vena cava (arrowhead). (F) HE staining (10×10) confirmed congestion across the central vein, with thinning and necrosis of adjoining hepatocytes. |
 |
Determine 2 Totally different ranges of heterogeneous enhancement on CT pictures of sufferers with hepatic sinusoidal obstruction syndrome. (A) Degree 1, delicate and restricted patchy enhancement (arrowhead). (B) Degree 2, reasonable confluent patchy enhancement (arrowhead). (C) Degree 3, extreme diffuse confluent patchy enhancement (arrowhead). |
On the identical time, the imaging manifestations of hepatomegaly, gallbladder wall thickening, and hepatic primary veins stenosis have been considerably extra apparent in HSOS sufferers than in BCS sufferers. Their prevalence charges of those three manifestations in HSOS sufferers have been 85% (17/20), 90% (18/20), and 80% (16/20), respectively, which have been considerably totally different from these of the BCS group (p ˂ 0.05) (Table 2). Regardless of the narrowing of the principle hepatic veins, the liver parenchyma surrounding the three hepatic veins exhibited enhancement within the venous and delayed phases, which was highlighted within the background of decreased enhancement of liver parenchyma elsewhere. The sort of enhancement was known as clover-like enhancement (Figure 1D and E), a attribute imaging manifestation of HSOS. The Hematoxylin and Eosin (HE) staining of the liver biopsy confirmed congestion across the central vein with thinning and necrosis of adjoining hepatocytes (Figure 1F).
Dialogue
Etiological and Pathological Foundation of HSOS
HSOS typically happens after a bone marrow transplant or after taking sure Chinese language natural medicines containing PA, particularly in sufferers with a historical past of taking Gynura segetum. Chemotherapies utilized in colorectal liver metastases have additionally been recognized as a threat issue for HSOS, notably the utilization of oxaliplatin (OX).7 Research have proven that endothelial cell harm within the hepatic sinusoids and central vein area, intimal hyperplasia, and fibrosis of venules trigger the obstruction of blood outflow and subsequent acute hepatocyte necrosis. Associated pathological research additionally help the aforementioned view, particularly, necrosis of hepatocytes within the heart of the liver lobules, and the dilation and bleeding of sinusoids across the central vein.8 Though liver biopsy is the golden commonplace for the prognosis of HSOS, familiarity with typical imaging options by clinicians and imaging physicians remains to be useful for the early prognosis and remedy of the illness.
Scientific and Laboratory Parameters of HSOS
HSOS and BCS are the 2 most typical ailments characterised by post-sinusoidal portal hypertension as a result of obstruction of hepatic venous outflow. Nonetheless, they contain totally different websites, that are keys to analyzing their scientific and imaging options.9
The commonest scientific manifestations of HSOS are stomach distension, lack of urge for food, fatigue, and jaundice, that are primarily brought on by liver dysfunction on account of acute liver cell harm, central venous congestion, haemorrhage, and hepatocellular necrosis.10 On this examine, it was noticed that the degrees of aspartate and alanine aminotransferase have been considerably greater within the HSOP sufferers than these within the BCS sufferers, suggesting that acute liver harm was extra extreme within the sufferers with HSOS, whereas BCS is a continual pathological course of with the well-compensated liver. The degrees of alkaline phosphatase and glutamyl transpeptidase have been additionally considerably greater within the sufferers with HSOS than these within the sufferers with BCS, as a result of obstruction of the bile duct and bile secretion impairment brought on by acute liver harm. Research have instructed that sufferers with HSOS could have renal dysfunction and their prognosis of kidney harm is poor, which was per an commentary that the degrees of creatinine and urea nitrogen have been considerably greater in sufferers with HSOS than these in sufferers with BCS on this examine.
Coagulation dysfunction performs an essential position within the incidence and improvement of HSOS. Animal research have proven that Gynura segetum can cut back the variety of platelets and inhibit platelet aggregation in rats, resulting in extended coagulation time.11 This examine confirmed that the prothrombin time and the worldwide normalized ratio of the sufferers with HSOS have been elevated, which have been considerably totally different from BCS sufferers. It’s potential that the white blood cell, pink blood cell, and platelet counts of routine blood checks are decrease in BCS sufferers than these in HSOS sufferers as a result of continual course of BCS causes splenomegaly and hypersplenism. Nonetheless, solely white blood cell and pink blood cell counts have been noticed considerably decrease in BCS sufferers than HSOS sufferers, whereas there was no vital distinction in platelet counts between the 2 teams, which can be attributed to the lesser impact of Gynura segetum on the blood system of diseased people in contrast with that of wholesome people. Given the excessive incidence of pleural effusion and ascites in sufferers with HSOS, secondary an infection can’t be dominated out as a potential explanation for the excessive white blood cell counts in these sufferers.
HSOS Imaging Options
Ascites and hepatic parenchyma heterogeneous hypoattenuation are the most typical CT findings in HSOS and have been current in all HSOS sufferers. The heterogeneous enhancement of the liver parenchyma is a vital imaging characteristic of HSOS, and its pathological foundation was the obstruction of blood outflow as a result of necrosis of hepatocytes within the heart of the liver lobules with collectively the dilation and bleeding of sinusoids across the central veins. Due to this fact, in distinction to the background of diffuse hypoattenuation of liver parenchyma, the scattered or confluent areas of heterogeneous patchy and the map-like enhancement across the small branches of the portal vein on the portal venous section CT scans develop over time.12 Totally different levels and scopes of enhancements have been clearly noticed on this examine (Figure 2). Zhou et al13 confirmed that the diploma of patchy and the map-like enhancement have been considerably correlated with the scientific severity of HSOS and have been delicate diagnostic indicators of HSOS.
Hepatomegaly can also be a typical imaging manifestation of HSOS. Though nonspecific, it’s instructed that acute hepatocyte harm is brought on by the obstruction of acute hepatic venous outflow, which is totally different from continual outflow tract obstruction or stenosis in BCS. The acute obstruction of hepatic venous outflow is related to liver congestion and the thinning and necrosis of hepatocytes, and may be brought on by hypoproteinemia. On the identical time, the thickening of the gallbladder wall can also be attributed to the elevated resistance in venous blood circulation, which is totally different from the thickening and oedema brought on by cholecystitis. The stenosis of primary hepatic veins has been broadly accepted as an essential diagnostic imaging characteristic of HSOS.14 This examine noticed 75% of the HSOS sufferers with three main hepatic veins stenosis. Erturk et al15 proposed {that a} proper hepatic vein diameter < 4.5 mm extremely signifies HSOS and attributed it to the extreme obstruction of hepatic sinusoidal and venous outflow. As well as, the stenosis of the hepatic inferior vena cava, which is the reason for liver parenchymal swelling and the obstruction of hepatic venous outflow, was additionally a novel imaging manifestation of HSOS (Figure 1E).
The CT scans of some circumstances confirmed that the enhancement of hepatic tissues surrounding the three primary hepatic veins was larger than that of different hepatic tissues, however the enhancement was concentrated within the second porta hepatis and exhibited a clover-like sample (Figure 1D). Due to this fact, this enhancement was known as a clover-like enhancement on this examine. As well as, the liver parenchyma adjoining to the three primary hepatic veins accommodates many small draining veins, that are nonetheless in a state of perfusion operate and have comparatively small hemodynamic adjustments, thereby resulting in a comparatively regular enhancement of the close by liver parenchyma.13
Differential Prognosis of HSOS
HSOS and BCS are the 2 most typical ailments characterised by post-sinusoidal portal hypertension. Though they share related liver scientific manifestations and histological options, there are vital variations between them within the following elements: (1) When it comes to etiology, most sufferers with HSOS have a transparent historical past of administration of pyrrole alkaloid-containing medicine (similar to Gynura segetum), or bear radiotherapy and chemotherapy, and now have an acute liver harm, whereas most sufferers with BCS have a historical past of unexplained continual liver cirrhosis; (2) When it comes to scientific manifestations, HSOS has a brief course of illness, and the clinically manifests are acute hepatocyte harm, bile duct obstruction, and bile secretion impairment, whereas BCS has a comparatively longer course of illness and its scientific manifests are largely continual compensated cirrhosis or continual decompensated cirrhosis with hypersplenism; (3) When it comes to imaging options, HSOS is especially characterised by ascites, hepatomegaly, typical map-like heterogeneous enhancement, and clover-like enhancement accompanied by the stenosis of the principle hepatic veins or hepatic inferior vena cava. Nonetheless, the blood circulation of HSOS sufferers remains to be unobstructed. In distinction, BCS sufferers primarily have CT manifestations of continual liver illness, similar to liver cirrhosis and splenomegaly, marked occlusion or stenosis of the hepatic veins and/or the inferior vena cava with an open collateral circulation, such because the retroperitoneal azygos or hemiazygos veins (Figure 3).
 |
Determine 3 CT manifestations of Budd-Chiari syndrome. (A) Uneven strengthening of liver parenchyma (arrowhead) on delayed-phase CT scans. (B) Retroperitoneal azygos and hemiazygos vein tortuous and enlargement on delayed-phase CT scans (arrowhead). (C) The left and center hepatic veins don’t circulation into the inferior vena cava. Cardiophrenic angle varice (arrowhead). (D) Membranous occlusion of inferior vena cava (arrowhead). (E) The correct hepatic vein flows straight into the inferior vena cava on Digital subtraction angiography. (F) Retroperitoneal azygos and hemiazygos vein tortuous and enlargement on Digital subtraction angiography. |
This examine had the next limitations: (1) All of the HSOS sufferers have been recognized by biopsy, however the BCS sufferers have been recognized solely by imaging and scientific options with out biopsy; (2) The imaging evaluation was solely based mostly on scientific routine plain CT scans and contrast-enhanced CT scans, whereas didn’t contain magnetic resonance picture evaluation, which left room for additional enchancment of the great analysis of HSOS; (3) Each oxaliplatin and Gynura segetum could cause HSOS, however the HSOS brought on by oxaliplatin largely happens 6–8 cycles after administration, which has apparent dose-dependent traits. It has been confirmed by the related literature7 that the HSOS brought on by Gynura segetum was not dose-dependent. As well as, on this examine, the pattern dimension was small, so the 2 samples can’t be distinguished from one another on the efficiency of contrast-enhanced CT.
This examine summarized and analyzed the scientific and imaging options of HSOS, and offered deeper insights into the prognosis and remedy of HSOS for scientific and imaging physicians. The primary findings have been as follows: (1) All HSOS sufferers had a historical past of administration of Gynura segetum or related medicine, and related scientific and laboratory parameters instructed the acute hepatocyte harm and the obstruction of bile conduct; (2) The standard CT imaging options of HSOS have been ascites, heterogeneous hypoattenuation, map-like heterogeneous enhancement, stenosis of the principle hepatic veins and the hepatic inferior vena cava, and clover-like enhancement of the second porta hepatis. These scientific and laboratory traits and CT picture options present a adequate foundation for the early scientific prognosis of HSOS.
Creator Contributions
All of the authors made vital contributions to the work introduced right here, whether or not in conception, examine design, execution, knowledge acquisition, knowledge evaluation and interpretation, or in all these elements. All authors took half in drafting, revising or critically reviewing the article; gave closing approval of the model to be revealed; have agreed on the journal to which the article has been submitted; and conform to be accountable for all elements of the work.
Funding
This work was supported by the Roentgen particular fund for picture analysis of Jiangsu Medical Affiliation (SYH-32011500008 2021003) and the Jiangsu Most cancers Hospital Younger Abilities Plan (Jiangsu China).
Disclosure
Feng Dai and Wei Qiao are co-first authors for this examine. The authors declare no conflicts of curiosity on this work.
References
1. Helmy A. Assessment article: updates within the pathogenesis and remedy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther. 2006;23(1):11–25. doi:10.1111/j.1365-2036.2006.02742.x
2. Lin G, Wang JY, Li N, et al. Hepatic sinusoidal obstruction syndrome related to consumption of Gynura segetum. J Hepatol. 2011;54(4):666–673. doi:10.1016/j.jhep.2010.07.031
3. Soni N, Israrahmed A, Singh P, et al. Caput medusa: an indication of portal hypertension on case of continual Budd-Chiari syndrome. BMJ Case Rep. 2021;14(4):e242076. doi:10.1136/bcr-2021-242076
4. Balducci G, Sterpetti AV, Ventura M. A brief historical past of portal hypertension and of its administration. J Gastroenterol Hepatol. 2016;31(3):541–545. doi:10.1111/jgh.13200
5. Shi TT, He J, Zhuge YZ, et al. CT characteristic of hepatic veno-occlusive illness brought on by Gynura segetum. J Pract Radiol. 2016;32:875–878.
6. Kan XF, Ye J, Rong XX, et al. Diagnostic efficiency of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep. 2016;6(1):37998. doi:10.1038/srep37998
7. Cayet S, Pasco J, Dujardin F, et al. Diagnostic efficiency of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: radio-pathological correlation. Eur J Radiol. 2017;94:180–190. doi:10.1016/j.ejrad.2017.06.025
8. Yang XQ, Ye J, Li X, et al. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, scientific manifestations, prognosis, remedy, and outcomes. World J Gastroenterol. 2019;25(28):3753–3763. doi:10.3748/wjg.v25.i28.3753
9. Ulas DB, Soley S, Yusuf B. Hepatic venous outflow obstruction: three related syndromes. World J Gastrenterol. 2007;13(13):1912–1927. doi:10.3748/wjg.v13.i13.1912
10. Wang JY, Gao H. Tusanqi and hepatic sinusoidal obstruction syndrome. J Dig Dis. 2014;15(3):105–107. doi:10.1111/1751-2980.12112
11. Deleve LD, Shulman HM, McDonald GB. Poisonous harm to hepatic sinusoids: sinusoidal obstruction syndrome. Semin Liver Dis. 2002;22(1):27–42. doi:10.1055/s-2002-23204
12. Kan XF, Ye J, Rong XX, et al. Diagnostic efficiency of contrast-enhanced CT in pyrrolizidine Alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep. 2016;6(11):1–8.
13. Zhou H, Wang YX, Lou HY, et al. Hepatic sinusoidal obstruction syndrome brought on by natural drugs: CT and MRI options. Korean J Radiol. 2014;15(2):218–225. doi:10.3348/kjr.2014.15.2.218
14. Solar ZY, Kang JM, Zhang YC. Hepatic veno-occlusive illness associated to Gynura segetum: a case report. Medication (Baltimore). 2018;97(17):e0552. doi:10.1097/MD.0000000000010552
15. Erturk SM, Mortele KJ, Binkert CA, et al. CT options of hepatic veno occlusive illness and hepatic graft-versus-host illness in sufferers after hematopoietic stem cell transplantation. AJR. 2006;186(6):1497–1501. doi:10.2214/AJR.05.0539
